Table 2 Patients' characteristics at study enrolment
Patient characteristics | n (%) |
|---|---|
Total N | 180 |
Sex†|  |
   Men: n (%) | 51 (28) |
   Women: n (%) | 128 (72) |
Age: median (IQR) | 35 (30-41) |
Location†|  |
   Frontal: n (%) | 68 (39) |
   Temporal: n (%) | 27 (15) |
   Occipital: n (%) | 9 (5) |
   Vertex: n (%) | 2 (1) |
   Generalized: n (%) | 69 (39) |
Headache score†: median (IQR) | 8 (6-10) |
Headache duration (days)†: median (IQR) | 10 (5-21) |
WHO stage†: |  |
   I or II: n (%) | 38 (21) |
   III: n (%) | 73 (41) |
   IV: n (%) | 66 (37) |
Patient on ART: n (%) | 53 (29) |
Karnofsky performance score†: median (IQR) | 70 (60-80) |
CD4 count†: median (IQR) | 108 (20-239) |
Workup classification†: |  |
   Focal/febrile | 3 (2) |
   Non-focal/febrile | 19 (11) |
   Focal/afebrile | 11 (6) |
   Non-focal/afebrile | 144 (81) |